Drug Development
-
Life Technologies appoints president of medical sciences
Life Technologies announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as president, medical sciences.
Drug Development | 10 February 2012
-
PBL InterferonSource collaborates with AVANZA
PBL InterferonSource (PBL) and AVANZA Laboratories announced collaboration between their two organizations that will focus on enhancing their ability to service the biopharmaceutical industry.
Drug Development | 13 January 2012
-
ICON Acquires BeijingWits Medical Consulting
ICON has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting, a leading CRO in China. The transaction is expected to close in the first quarter of 2012.
Drug Development | 11 January 2012
-
ICON Medical Imaging is rated as top provider in imaging industry survey
ICON announced that its medical imaging division was rated as the top provider of imaging services according to an industry survey conducted by Blue Pyramid Consulting, an affiliate of the Avoca Group.
Drug Development | 05 January 2012
-
ICON Development Solutions appoints general manager of Asia Pacific
ICON announced that its development solutions division has appointed Dr Daniel Tang as general manager, Asia Pacific. Dr Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.
Drug Development | 12 December 2011
-
Bio-Images and Medimetrics partner to deliver the next generation of smart pill technology
IntelliCap set to speed up clinical research as part of innovative drug delivery package.
Drug Development | 25 October 2011
-
Agilent Technologies and University of Technology, Sydney, open joint nuclear magnet resonance facility
NMR facility will be home to cutting-edge technology to support a range of UTS staff and student research projects.
Drug Development | 20 October 2011
-
Nuvilex’s affiliate presents Cell in a Box technology in Seoul
BIO KOREA 2011 attracted over 4,500 attendees.
Drug Development | 14 October 2011
-
Launch of BioLynx provides a boost for the international malaria research community
New NUS spin-off company launches at TechVenture 2011.
Drug Development | 12 October 2011
-
Bi-axial bioreactor set to revolutionise pre-clinical trials in the field of regenerative medicine.
Technology jointly developed by National University of Singapore and Singapore Polytechnic, and commercialised by local start-up company.
Drug Development | 10 October 2011
